NCT03150368View on ClinicalTrials.gov

Extended Use of ModraDoc006/r

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

May 16, 2018

Study Completion Date

May 16, 2019

Conditions
Advanced Solid Tumours
Interventions
DRUG

ModraDoc006/r

Treatment with weekly ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets

Trial Locations (1)

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam

Sponsors
All Listed Sponsors
lead

Modra Pharmaceuticals

INDUSTRY

NCT03150368 - Extended Use of ModraDoc006/r | Biotech Hunter | Biotech Hunter